Garand Mathieu, Huang Susie S Y, Goessling Lisa S, Santillan Donna A, Santillan Mark K, Brar Anoop, Wylie Todd N, Wylie Kristine M, Eghtesady Pirooz
Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
Microorganisms. 2022 Sep 28;10(10):1925. doi: 10.3390/microorganisms10101925.
Human pegivirus (HPgV) is best known for persistent, presumably non-pathogenic, infection and a propensity to co-infect with human immunodeficiency virus or hepatitis C virus. However, unique attributes, such as the increased risk of malignancy or immune modulation, have been recently recognized for HPgV. We have identified a unique case of a woman with high levels HPgV infection in two pregnancies, which occurred 4 years apart and without evidence of human immunodeficiency virus or hepatitis C virus infection. The second pregnancy was complicated by congenital heart disease. A high level of HPgV infection was detected in the maternal blood from different trimesters by RT-PCR and identified as HPgV type 1 genotype 2 in both pregnancies. In the second pregnancy, the decidua and intervillous tissue of the placenta were positive for HPgV by PCR but not the chorion or cord blood (from both pregnancies), suggesting no vertical transmission despite high levels of viremia. The HPgV genome sequence was remarkably conserved over the 4 years. Using VirScan, sera antibodies for HPgV were detected in the first trimester of both pregnancies. We observed the same anti-HPgV antibodies against the non-structural NS5 protein in both pregnancies, suggesting a similar non-E2 protein humoral immune response over time. To the best of our knowledge, this is the first report of persistent HPgV infection involving placental tissues with no clear indication of vertical transmission. Our results reveal a more elaborate viral-host interaction than previously reported, expand our knowledge about tropism, and opens avenues for exploring the replication sites of this virus.
人pegivirus(HPgV)以持续感染(可能无致病性)以及与人免疫缺陷病毒或丙型肝炎病毒合并感染的倾向而闻名。然而,HPgV最近被发现具有一些独特的特性,例如恶性肿瘤风险增加或免疫调节作用。我们发现了一个独特的病例,一名女性在相隔4年的两次妊娠中均感染了高水平的HPgV,且没有人类免疫缺陷病毒或丙型肝炎病毒感染的证据。第二次妊娠并发先天性心脏病。通过逆转录聚合酶链反应(RT-PCR)在不同孕期的母血中检测到高水平的HPgV感染,两次妊娠均鉴定为1型HPgV基因2型。在第二次妊娠中,胎盘的蜕膜和绒毛间隙组织通过聚合酶链反应检测HPgV呈阳性,但绒毛膜或脐带血(两次妊娠)均为阴性,这表明尽管病毒血症水平很高,但没有垂直传播。HPgV基因组序列在这4年中非常保守。使用VirScan,在两次妊娠的孕早期均检测到针对HPgV的血清抗体。我们在两次妊娠中均观察到针对非结构NS5蛋白的相同抗HPgV抗体,这表明随着时间的推移,非E2蛋白的体液免疫反应相似。据我们所知,这是首次报道持续的HPgV感染累及胎盘组织但无明确垂直传播迹象。我们的结果揭示了一种比先前报道更为复杂的病毒-宿主相互作用,扩展了我们对嗜性的认识,并为探索该病毒的复制位点开辟了途径。